SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferation.
Endocr J. 2020 Jan 28;67(1):99-106. doi: 10.1507/endocrj.EJ19-0428. Epub 2019 Nov 27.
Endocr J. 2020.
PMID: 31776304
Free article.